A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Main Inclusion Criteria:

• Written informed consent

• General good health

• History of SAR to short ragweed pollen for 2 years immediately preceding the study

• Demonstrated sensitivity to short ragweed known to induce SAR through a standard skinprick test

Main Exclusion Criteria:

• Clinically significant physical finding of nasal anatomical deformities causinggreater than 50% obstruction, including but not limited to nasal polyps, septaldefects, respiratory tract malformations, nasal trauma or surgery

• Known hypersensitivity to any corticosteroid

• History of a respiratory infection or disorder including but not limited tobronchitis, pneumonia, chronic sinusitis, influenza or SARS (severe acute respiratorysyndrome) within 14 days preceding the Screening Visit

• History of alcohol or drug abuse within 2 years preceding the Screening Visit

• Active asthma requiring treatment of inhaled or systemic corticosteroids and/orroutine use of beta-agonists or any controller drugs

• Use of antibiotic therapy for acute conditions within 14 days preceding the ScreeningVisit

• Exposure to systemic corticosteroids for any indication, chronic or intermittentwithin 60 days preceding the Screening Visit